Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms ...
In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...
Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...
Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM, Advanced Micro Devices Inc. AMD, and Meta ...
EDT Cathie Wood’s ARK Investment bought 171K shares of Tempus AI (TEM) todayLight Up your Portfolio with Spark:Easily identify stocks' ...
Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have received an average recommendation of “Buy” from the seven ...
Bernstein analyst Peter Weed maintained a Buy rating on Gitlab (GTLB – Research Report) yesterday and set a price target of $76.00. The ...
EDT Cathie Wood’s ARK Investment bought 113K shares of GitLab (GTLB) todayLight Up your Portfolio with Spark:Easily identify stocks' ...
Investors are rushing to invest in quantum computing, perhaps the next big idea to fuel the artificial intelligence ...